Streptococcus Vaccine Medium - BioReagent

Cat. No.: S1528511

GRADE & PURITY BioReagent

Storage

Room temperature

Shipped In

Normal

Visão geral

For cultivating Streptococcus, used in the production and testing of inactivated swine and ovine Streptococcus vaccines

Specifications

Especificações e pureza

BioReagent

Condições de armazenamento de armazenamento

Room temperature

Enviado em

Normal

Grau

BioReagent

Product Line

biological_products

Application Protocols

Item-specific facts (from Product Data)

• Detailed preparation instructions, composition, and target strains are not specified for this item; refer to product label and CoA/Spec Sheet.

General preparation and use (literature/general; adapt to your SOPs)

1. Reconstitution

• If supplied as powder: Weigh the recommended mass per liter (per label). Add ~80–90% of the final volume of Type 1 water under stirring. Mix until fully dispersed. Rinse container to recover fines and bring to volume. If solution is turbid, allow to hydrate for 10–20 min with gentle stirring.

2. pH check and adjustment

• Measure pH at room temperature. If required, adjust with sterile HCl/NaOH. Note that autoclaving can shift pH; confirm after sterilization.

3. Sterilization

• Autoclave at 121 °C, 15 psi for 15–20 min (literature) unless the label instructs otherwise. For heat‑labile formulations, sterile‑filter (0.22 µm) into sterile vessels.

4. Supplements (if any)

• Aseptically add filter‑sterilized supplements (e.g., specific carbohydrates, vitamins) after the base medium has cooled to room temperature.

5. Inoculation and incubation

• Inoculate with a pure Streptococcus culture under aseptic conditions. Incubate at the strain’s recommended temperature (commonly 30–37 °C, literature) under appropriate atmosphere (microaerophilic/CO2 as needed). Monitor OD600, pH, and metabolites.

6. Harvest and disposal

• Harvest cells or supernatant as required. Decontaminate all waste by autoclaving or chemical disinfection per biosafety policy.

Quality checks

• Perform growth promotion testing with relevant strains. Record pH, clarity, and sterility controls for each lot/preparation.

Biological Roles

Applicability

• This section addresses the biological context of the intended organisms rather than a single molecular target, since the product is a culture medium.

General background (literature/general)

• Streptococcus is a diverse genus of Gram‑positive bacteria, many species of which are lactic acid bacteria that ferment carbohydrates primarily to lactate. Growth is influenced by complex nitrogen sources (peptides/amino acids), vitamins, and buffering capacity due to acid production.
• For vaccine research, consistent expression of surface structures (e.g., polysaccharide capsules, M‑like proteins in certain species) can be medium‑dependent, with carbon source and redox conditions modulating phenotype.
• Media for streptococci often benefit from enriched components (yeast extract, peptones) and controlled pH (near neutral) to counteract acidification during exponential growth. CO2 or microaerophilic conditions may improve growth for fastidious species.

Practical implications

• When comparing media, monitor biomass yield, viability, and antigen quantity/quality under standardized culture conditions. Validate that the medium supports the specific serogroup/strain used in your workflow.
• For omics studies (proteomics, glycomics), define medium composition as precisely as possible or adopt semi‑defined/defined formulations to reduce confounders; complex media may introduce batch effects.

Buffer Applications

Applicability

• This product is a complete culture medium rather than a standalone buffer. It is not typically used solely for buffering purposes.

General guidance (literature/general)

• Streptococcal media typically include a buffering system (e.g., phosphate, carbonate, or organic buffers) to maintain near‑neutral pH during carbohydrate fermentation. Exact buffer composition and capacity for this item are not specified; refer to CoA/Spec Sheet.
• For processes sensitive to pH drift, consider external pH control (bioreactor base addition) or feed strategies that limit rapid acidification. In small‑scale flasks, higher buffer capacity or reduced sugar concentration can help stabilize pH.
• If downstream assays require defined ionic strength, prepare a matched blank of the medium and verify pH and conductivity after sterilization, as both can shift on autoclaving (literature).

Preparation notes

• Adjust pH, if needed, before sterilization and confirm post‑sterilization. Use sterile techniques to add heat‑labile buffering components after cooling.

Green Alternatives

Context

• Culture media are inherently water‑based and generally align with green chemistry principles related to solvent selection. Environmental impact is driven more by component sourcing, sterilization energy, and single‑use plastics.

Greener choices (literature/general)

• Prefer plant‑derived peptones/tryptones and yeast extract over animal‑derived hydrolysates to reduce animal sourcing and batch variability, when biologically compatible with the target Streptococcus strain.
• Use concentrated stock solutions to minimize packaging. Employ reusable glassware where validated, and optimize autoclave loads/cycles to reduce energy use.
• Consider low‑phosphate or buffered‑efficient formulations to limit eutrophication potential in effluents; neutralize and treat waste prior to disposal.

Tradeoffs

• Plant hydrolysates can alter growth profiles or antigen expression relative to animal-based components; empirical re‑optimization may be required.
• Filter sterilization reduces thermal energy but may not be suitable for turbid or particulate‑rich formulations and requires validated sterility assurance.

Item-specific note

• Composition and origin of components for this item are not specified; refer to CoA/Spec Sheet and choose practices aligned with your laboratory’s sustainability and biosafety requirements.

Pharmaceutical Uses

Item-specific facts (from Product Data)

• Research use only. Not for human or animal therapeutic or diagnostic use.

General context (literature/general; no clinical claims)

• In pharmaceutical process development, specialized culture media are used during early research and non‑GMP studies to cultivate organisms and generate biomaterial for analytical characterization, antigen discovery, and upstream optimization.
• For vaccine‑related R&D with streptococci, media choice affects cell density, antigen yield, and product quality attributes. Transition to GMP manufacturing typically involves locked formulations, supplier qualification, and extensive growth promotion validation.
• Media can be used for seed train development, reference strain maintenance, and small‑scale bioreactor runs to establish scalable parameters (pH control, feeding, DO), prior to tech transfer to GMP‑compliant formulations.

Compliance note

• This item is not certified to pharmacopeial monographs or GMP standards based on provided information. Requirements such as TSE/BSE statements, adventitious agent testing, endotoxin limits, and sterility assurance are application‑specific and, if needed, must be sourced from the supplier. For this item, such attributes are not specified; refer to CoA/Spec Sheet.

Physical Properties

Item-specific facts (from Product Data)

• Appearance: Not specified for this item; refer to CoA/Spec Sheet.
• Storage conditions: Room temperature. Shipped at ambient conditions (Normal).

General properties (literature/general; may vary by lot and supplier)

• Physical form: Culture media are commonly supplied as dry, free‑flowing powders or as ready‑to‑use liquids. Reconstitution, if powdered, is typically in purified water.
• Solubility: Formulated to be water‑soluble/dispensable; insoluble particulates may reflect complex components (e.g., protein hydrolysates) and generally dissolve upon mixing/sterilization.
• Typical solution pH: Often near neutrality after preparation (e.g., ~6.8–7.4 at 25 °C, literature), but exact pH and adjustment requirements are formulation‑dependent.
• Osmolality/conductivity: Formulation‑dependent; optimized to support streptococcal growth. Not specified for this item; refer to CoA/Spec Sheet.
• Sterility: As supplied, media are non‑sterile unless explicitly labeled sterile. Not specified for this item; refer to CoA/Spec Sheet.

Practical notes

• Use Type 1 or equivalent water for preparation to minimize variability from ions/organics.
• If autoclaving is used, note that some components (e.g., sugars) can caramelize; follow supplier instructions for sterilization method and time.
• Filter sterilization (0.22 µm) may be preferred for heat‑labile formulations.

Quality and Grades

Item-specific facts (from Product Data)

• Grade: BioReagent.
• Item-specific specifications (e.g., sterility, endotoxin, pH, fill mass tolerance): Not specified for this item; refer to CoA/Spec Sheet.

What BioReagent typically implies (literature/general)

• BioReagent grade denotes suitability for routine biological research workflows, including microbiology and cell culture–adjacent applications, with attention to bioburden, trace contaminants, and performance consistency.
• It does not by itself indicate GMP compliance or suitability for clinical manufacturing; for regulated processes, qualification and supplier audits are required.

Quality considerations for streptococcal media (general guidance)

• Critical attributes often monitored include: appearance (homogeneity, color), solubility/clarity, pH after reconstitution, growth promotion testing with representative Streptococcus strains, total nitrogen, ash, and conductivity.
• Optional controls may include heavy metal limits, sugar content (if present), and lot‑to‑lot reproducibility metrics. For endotoxin and mycoplasma bioburden limits: Not specified for this item; refer to CoA/Spec Sheet.

Documentation

• For definitive acceptance criteria, refer to the lot‑specific CoA/Specification Sheet and product label. Where performance data (e.g., growth promotion results) are provided, use them to qualify the lot for your application.

Reaction and Applications

Applicability

• Not a reagent for chemical reactions. This product is intended for biological culture applications.

Research applications (literature/general)

• Cultivation and scale‑up of Streptococcus spp. for research production of cellular biomass, surface antigens, or secreted products relevant to vaccine research and process development.
• Growth promotion and media optimization studies (DoE) to map nutrient requirements, carbon source utilization, and buffering strategies that modulate acid stress in lactic streptococci.
• Seed train development for bioreactor inoculation; adaptation from shake‑flask to controlled fermenters with pH and dissolved oxygen management.
• Analytical method development: evaluation of growth kinetics (OD600, CFU), metabolite profiling (lactate, residual sugars), and antigen yield under different medium formulations.

Practical tips

• Streptococci commonly prefer microaerophilic or facultative anaerobic conditions; CO2 supplementation and reduced redox potential can enhance growth (literature). Control pH to mitigate acidification from carbohydrate metabolism.
• Degassing/oxygen control: For more fastidious strains, deoxygenation of media (boiling and cooling under N2) and redox indicators (e.g., resazurin) are used in literature workflows.
• Media selection can strongly influence capsule and M‑protein expression in some streptococci; evaluate phenotype under intended process conditions. Composition for this item is not specified; tailor optimization accordingly.

Reaction Conditions

Not applicable to chemical reactions

• As a culture medium, it does not participate in named organic reactions. Instead, culture conditions (biological) are relevant. See Application Protocols for general preparation and cultivation guidance.

Safety and Handling

Item-specific facts (from Product Data)

• GHS classification, pictograms, signal word, H‑statements: Not specified for this item; refer to SDS.
• Storage conditions: Room temperature. Shipped at ambient conditions (Normal).
• Research use note: For research use only.

General safety guidance (literature/general)

• As supplied, typical culture media are not classified as hazardous; however, always review the SDS for the specific lot.
• Primary hazard arises after inoculation: cultures of Streptococcus spp. are biosafety‑relevant. Handle all inoculated media under appropriate biosafety procedures (e.g., BSL‑2 practices), in accordance with institutional IBC policies.
• PPE: Lab coat, safety glasses, disposable nitrile gloves; use a certified biological safety cabinet for aerosol‑generating steps.
• Engineering controls: Work on clean bench or BSC; use sealed tubes/flasks with proper venting to limit aerosol formation.
• Incompatibilities: Avoid strong oxidizers/acids/bases during storage. For powdered media, avoid moisture uptake; keep container tightly closed and desiccated as applicable.
• First aid (overview; defer to SDS): If contact with eyes/skin, rinse with water. If inhaled (powder), move to fresh air. If ingested, rinse mouth. Seek medical advice if symptoms persist.
• Decontamination: Autoclave spent or contaminated media and disposables (121 °C, 15 psi, ≥20–30 min; literature) or treat with appropriate disinfectant (e.g., freshly made 10% bleach) before disposal per local regulations.
• Spill response: Avoid creating dust; dampen powder before collection. Disinfect area if biological contamination is suspected.

Solvent Selection

Applicability

• This product is a culture medium, not a small‑molecule solute; solvent selection is generally not a variable beyond water quality.

General guidance (literature/general)

• Primary solvent: Purified water (ASTM/CLSI Type 1 or equivalent). Lower water quality can introduce inhibitory ions/organics and increase variability.
• Miscibility: Designed for complete dispersion in water; organic solvents are not applicable and can inhibit streptococcal growth.
• pH control: If pH adjustment is required, use sterile acid/base solutions (e.g., HCl/NaOH) and verify after sterilization, as autoclaving can shift pH.

Comparison and selection tips

• When choosing among streptococcal media, key differentiators are carbon source (e.g., glucose vs. alternative carbohydrates), buffering capacity, protein hydrolysate source (animal vs. plant), and presence/absence of supplements (e.g., yeast extract). These factors influence growth rate, acid production, and antigen expression. Composition for this item is not specified; refer to CoA/Spec Sheet.
• If heat‑labile supplements are required (e.g., certain vitamins), prepare them separately in water and sterile‑filter, then aseptically add to the cooled sterile base medium.

Storage and Reconstitution

Item-specific facts (from Product Data)

• Storage: Room temperature. Shipped under normal ambient conditions.
• Appearance and exact reconstitution instructions: Not specified for this item; refer to CoA/Spec Sheet.

General guidance (literature/general)

• Keep container tightly closed, dry, and protected from humidity and light. For powdered media, store in original packaging with desiccant as applicable. Avoid temperature extremes and repeated opening that can introduce moisture.
• Shelf life: Follow the product label; monitor for caking, color change, or odor as signs of degradation or contamination.
• Reconstitution: Use freshly prepared Type 1 water. Dissolve the labeled mass per liter with vigorous stirring; allow complete hydration before sterilization. If necessary, pre‑warm water to ~25–30 °C to aid dissolution; avoid excessive heat that can alter components.
• Sterile storage: After sterilization, store liquid medium at 2–8 °C for short term (e.g., days to a few weeks, literature) in sterile, sealed containers. Warm to use and mix to resuspend any precipitates. Discard if turbidity or contamination appears in uninoculated controls.
• Freeze‑thaw: Avoid repeated freeze‑thaw of prepared media; if freezing aliquots, validate performance post‑thaw as some components may precipitate or degrade.

Documentation

• Record preparation date, lot numbers (medium, supplements), pH before/after sterilization, and sterilization parameters to support reproducibility and traceability.

Structure and Identity

Item-specific facts (from Product Data)

• Product name: Streptococcus Vaccine Medium (SKU: S1528511)
• Grade: BioReagent
• CAS, CID, InChIKey, SMILES: Not assigned for complex culture media.
• Molecular formula / molecular weight: Not applicable to complex, multi‑component media.

General description (literature/general)

• This product is a complex, nutrient medium intended for cultivation of Streptococcus species for vaccine research and process development. Such media are typically mixtures of peptides/peptones, amino acids, carbohydrates, minerals, vitamins, and buffering salts dissolved in water. Because composition can be proprietary or undefined, conventional single-compound identifiers (CAS, InChIKey, SMILES) do not apply.
• Structural features: As a formulation rather than a single molecule, it comprises heterogeneous organic/inorganic constituents; there is no single 2D structure to depict.

Identity and traceability

• As supplied by Aladdin Scientific, identity is established by product label, lot number, and accompanying CoA/Specification Sheet. For any analyte-specific identity tests (e.g., total nitrogen, ash, conductivity, osmolality), consult the lot CoA.

Synthetic Utility

Not typically applicable

• This is a biological culture medium and is not used as a reagent in organic synthesis. For applications relevant to this product, see the sections Reaction & Applications, Biological Roles, and Application Protocols.

Target Specificity

Not applicable

• This product is not an antibody, probe, or affinity reagent. It does not have target specificity parameters such as clone, isotype, or species reactivity.